-
Spectrum Pharmaceuticals Gains 5% After Company Confirms FDA Review Of New Drug
Friday, February 19, 2016 - 12:03pm | 118Read More...Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) were trading higher by nearly 5 percent late Friday morning after the company announced that the U.S. Food and Drug Administration (FDA) has accepted its EOquin for New Drug Application (NDA) for review. EOquin (apaziquone for intravesical...
